1. Home
  2. SYRE vs SBR Comparison

SYRE vs SBR Comparison

Compare SYRE & SBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • SBR
  • Stock Information
  • Founded
  • SYRE 2013
  • SBR 1982
  • Country
  • SYRE United States
  • SBR United States
  • Employees
  • SYRE N/A
  • SBR N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • SBR Oil & Gas Production
  • Sector
  • SYRE Health Care
  • SBR Energy
  • Exchange
  • SYRE Nasdaq
  • SBR Nasdaq
  • Market Cap
  • SYRE 1.1B
  • SBR 972.2M
  • IPO Year
  • SYRE 2016
  • SBR N/A
  • Fundamental
  • Price
  • SYRE $16.26
  • SBR $65.89
  • Analyst Decision
  • SYRE Buy
  • SBR
  • Analyst Count
  • SYRE 5
  • SBR 0
  • Target Price
  • SYRE $55.00
  • SBR N/A
  • AVG Volume (30 Days)
  • SYRE 545.5K
  • SBR 24.2K
  • Earning Date
  • SYRE 08-06-2025
  • SBR 01-01-0001
  • Dividend Yield
  • SYRE N/A
  • SBR 8.31%
  • EPS Growth
  • SYRE N/A
  • SBR N/A
  • EPS
  • SYRE N/A
  • SBR 5.34
  • Revenue
  • SYRE N/A
  • SBR $81,761,891.00
  • Revenue This Year
  • SYRE N/A
  • SBR N/A
  • Revenue Next Year
  • SYRE N/A
  • SBR N/A
  • P/E Ratio
  • SYRE N/A
  • SBR $12.41
  • Revenue Growth
  • SYRE N/A
  • SBR N/A
  • 52 Week Low
  • SYRE $10.91
  • SBR $58.25
  • 52 Week High
  • SYRE $40.26
  • SBR $70.20
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 48.34
  • SBR 47.25
  • Support Level
  • SYRE $16.43
  • SBR $66.01
  • Resistance Level
  • SYRE $17.70
  • SBR $66.91
  • Average True Range (ATR)
  • SYRE 0.99
  • SBR 0.71
  • MACD
  • SYRE -0.02
  • SBR 0.02
  • Stochastic Oscillator
  • SYRE 37.17
  • SBR 36.65

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About SBR Sabine Royalty Trust

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

Share on Social Networks: